Considering the potential benefits of allogeneic cell therapies, several researchers and industry stakeholders have been continuously exploring such therapy candidates for applications across a myriad of disease indications
Roots Analysis is pleased to announce the publication of its recent study, titled, “Allogeneic Cell Therapy Market, 2023-2035.”
The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders in this market, across different geographies. Amongst other elements, the market report includes:
- A detailed assessment of the overall landscape of allogeneic cell therapies and allogeneic therapy developers based on several relevant parameters.
- A detailed analysis of the partnerships established between stakeholders engaged in this industry, since 2019
- An analysis of the funding and investments that have been made into companies developing allogeneic cell therapies
- An analysis of completed and ongoing clinical trials related to allogeneic cell therapies, based on several relevant parameters
- An insightful analysis, highlighting the key opinion leaders (KOLs) investigating clinical trials related to allogeneic cell therapies.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Cell Therapy
- Stem Cell
- Virus-Specific T-Cell
- Regulatory T-Cell
- Source of Cell
- Bone Marrow / Matrix
- Adipose Tissue
- Peripheral Blood
- Umbilical Cord
- Placenta
- Others
- Target Indication
- Infectious Diseases
- Chronic Heart Failure
- Crohn’s Disease
- Ischemic Stroke
- Hematological Cancer
- Bone Diseases
- Critical Limb Ischemia
- Graft versus Host Disease
- Duchenne Muscular Dystrophy
- Epidermolysis Bullosa
- Diabetic Foot Ulcer
- Others
- Therapeutic Area
- Post-Transplant Infections
- Cardiovascular Disorders
- Autoimmune / Inflammatory Disorders
- Cerebrovascular Disorders
- Oncological Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Genetic Disorders
- Others
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific and Rest of the World
Key companies (based on the number of allogeneic cell therapies being developed; arranged in alphabetical order) covered in the report
- Artiva Biotherapeutics
- Allogene Therapeutics
- Celularity
- Cellenkos
- Cell2Cure
- CHABiotech
- CRISPR Therapeutics
- Fate Therapeutics
- Fundamenta Therapeutics
- GC Cell
- Mesoblast
- Nanjing Bioheng Biotech
- Stemedica Cell Technologies
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/allogeneic-cell-therapy-market.html
News article
Blockchain in Drug Discovery and Clinical Trials Market
Learn from experts: do you know about these emerging industry trends?
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services
Top 10 Quantum Computing Companies Transforming Drug Discovery
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.coma